Archives: Speakers

Victor is an insurance industry veteran with 15+ years of experience delivering digital transformation initiatives at market-leading insurers such as Zurich Financial Services and Swiss Re. Victor now leads transformation in the complex payments ecosystem, helping brokers, insurers, and others deploy modern payments methods, delivering on changing customer requirements, business agility, and reducing TCO.

Glen joined Luxoft in 2021 from IBM.  His work is focused on insurance analytics use cases, and supporting and guiding data science, engineering and sales colleagues in partnering with clients.

Before moving to the technology sector, after serving in law enforcement Glen first entered the insurance industry in Australia.  This was followed by roles in insurers operating in the UK and Europe, with exposure to other regions too.  He has held four Executive Director positions and Senior Management roles, worked for some of the world’s largest businesses, prominent brands, a scale-up, not-for-profit organization, formed part of industry strategy and milestone initiatives and also as an independent consultant to insurance and wider clients.

Glen is viewed by peers as a source of creativity, pragmatism and fresh/different thinking and perspectives. He possesses comprehensive knowledge of insurance and the supply chain, including the wide opportunities for change and modernization. In particular, he’s widely regarded as a specialist in mitigating insurance fraud through the full policy life cycle; point of quote, sale, mid-term adjustment and claim.

Richard Bennett is Senior Director and Therapeutic Strategy Lead in the Neuroscience franchise at Worldwide Clinical Trials. With two decades in the industry, he has advanced through the traditional clinical operations roles such as clinical research associate and clinical trial manager and has spent many years as a leader of clinical development programs in both the larger pharma and biotech setting. He has worked on neuromuscular disorders, rare diseases, critical care, pain and palliative care, dermatology, and epidemiology programs. His direct experience working with large pharma and small and emerging biotech firms has given him a deep understanding of the needs of our sponsors

Malia Lewin is global head of strategy, ensuring both clinical and market fit for Teckro products. An attorney by training, Malia Lewin has over 20 years of experience in the life sciences industry. Passionate about getting life-changing healthcare innovations to patients, Malia has worked on behalf of non-profit organizations, pharmaceutical and biotechnology companies, hospital systems, and technology companies to expedite the path of scientific discoveries from bench to clinic.

Most recently, Malia served as chief business officer of CherryCircle Software, where she led the global go-to-market strategy for QbDVision, a SaaS platform to optimize the development and manufacturing of drug products. Prior to that, she served as director of global oncology strategy at Veeva Systems, where she worked closely with clients in the oncology space to harness the power of technology to develop and commercialize oncology innovations. During her seven-year tenure as VP of client services and head of strategic operations at Rivermark, LLC (an IQVIA company), Malia led strategic consulting teams advising on the development, launch, and adoption of diagnostics and treatments, across therapeutic areas. This included the development of novel digital products for stakeholder mapping and engagement, network visualization and activation, and reporting and analytics. Earlier in her career, Malia had the opportunity to serve non-profit organizations as the founding CEO and executive director of the International Psoriasis Council and as lead partner of Networking and Affiliations at Ascension Health.

Malia holds Bachelor of Arts Degrees in English and in Women’s Studies from the University of Richmond and a Juris Doctor from The George Washington University Law School.